Inventiva
Manufacturing · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
50 Rue De Dijon, Daix, Bourgogne-Franche...Phone Number
+33 380447500Website
www.inventivapharma.comRevenue
<$5 MillionStock Symbol
IVAIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Inventiva
Inventiva is a clinical-stage biopharmaceutical company headquartered in France, specializing in the development of oral small molecule therapies. The company focuses on addressing significant unmet medical needs in areas such as fibrosis, lysosomal storage disorders, and oncology, aiming to advance innovative treatments that improve patient outcomes.Explore more
Inventiva Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Inventiva your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Inventiva
Earning: See what the market has to say on Inventiva recently announced quarterly report
Check out if Inventiva is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Inventiva had a recent Job posting/layoffs
Product Launch: Get notified when Inventiva launches new products
Inventiva, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Inventiva has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Inventiva has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Inventiva is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Inventiva is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Inventiva.
Inventiva financials insights
Gather financial insights about Inventiva, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Other Financing Round
$16.4M
Stock Offering
$107.7M
2023
Share Placement
$36.7M
2024
Private Equity
$99.6M
2025
Debt
$131M
2026
Debt
$151.2M
Inventiva Tech Stack
A closer look at the technologies used by Inventiva
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Inventiva News & Media
Inventiva to Present Multiple Abstracts at Paris MASH 2026
Daix (France), New York (New York, United States), September 8, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of an oral therapy for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announces the presentation of five abstracts at the 12th Paris MASH Meeting taking place September 10-11, 2026, at the Pasteur Institut in Paris, France.Chris Benecchi Named Inventiva’s New Chief Operating Officer
By Karen Roman Inventiva S.A. (Nasdaq: IVA) said it designated Chris Benecchi as Chief Operating Officer, having previously served as Chief Executive Officer of Motric Bio (an Aditum Bio company). Mr. Benecchi will lead the company’s operational side as Inventiva comes close to its NATiV3 Phase 3 study results of lanifibranor in MASH, expected for […] The post Chris Benecchi Named Inventiva’s New Chief Operating Officer appeared first on ExecEdge.Inventiva Appoints Chris Benecchi as Chief Operating Officer
Daix (France), New York City (New York, United States), August 31, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of an oral therapy for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced the appointment of Chris Benecchi as Chief Operating Officer. A proven biopharmaceutical leader with extensive experience in building organizations, preparing medicinInventiva (NASDAQ: IVA) revises debt proceeds and outlines 2026 cash runway
Amended disclosure lifts Tranche C proceeds to €55M and details €166.1M cash, €67.8M deposits and financings that support operations into the second quarter of 2027.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Inventiva
Sign Up For FreeTo access detailed company insights
Inventiva is a clinical-stage biopharmaceutical company headquartered in France, specializing in the development of oral small molecule therapies. The company focuses on addressing significant unmet medical needs in areas such as fibrosis, lysosomal storage disorders, and oncology, aiming to advance innovative treatments that improve patient outcom... Read More
